Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN study

The GA2LEN chamber has been developed as a novel mobile allergen exposure chamber (AEC) allowing standardized multicenter trials in allergy. Hitherto, subjective nasal symptom scores have been the most often used outcome parameter, but in standardized modern trials objective parameters are preferred...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bölke, Georg (VerfasserIn) , Pfaar, Oliver (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Clinical and translational allergy
Year: 2017, Jahrgang: 7
ISSN:2045-7022
DOI:10.1186/s13601-017-0169-4
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s13601-017-0169-4
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13601-017-0169-4
Volltext
Verfasserangaben:Georg Boelke, Uwe Berger, Karl-Christian Bergmann, Carsten Bindslev-Jensen, Jean Bousquet, Julia Gildemeister, Marek Jutel, Oliver Pfaar, Torsten Sehlinger and Torsten Zuberbier
Beschreibung
Zusammenfassung:The GA2LEN chamber has been developed as a novel mobile allergen exposure chamber (AEC) allowing standardized multicenter trials in allergy. Hitherto, subjective nasal symptom scores have been the most often used outcome parameter, but in standardized modern trials objective parameters are preferred. Despite its practicability, the objective parameter peak nasal inspiratory flow (PNIF) has been rarely used for allergy trials in the setting of allergen exposure chambers. This study aims to evaluate PNIF as an outcome parameter for provocation studies in AECs.
Beschreibung:Published online: 17 September 2017
Gesehen am 25.06.2018
Im Titelzusatz ist die Zahl 2 hochgestellt
Beschreibung:Online Resource
ISSN:2045-7022
DOI:10.1186/s13601-017-0169-4